Bioceres Crop Solutions Corp.
BIOX
$4.47
-$0.02-0.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -29.09% | -23.90% | -20.28% | 18.31% | -9.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -29.09% | -23.90% | -20.28% | 18.31% | -9.62% |
| Cost of Revenue | -11.64% | -30.01% | -24.45% | 16.80% | 13.85% |
| Gross Profit | -46.27% | -13.00% | -13.13% | 20.98% | -24.87% |
| SG&A Expenses | -1.51% | 4.50% | -15.90% | 3.44% | -0.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -342.50% | -20.98% | -0.38% | 35.72% | 355.73% |
| Total Operating Expenses | -19.55% | -20.96% | -20.22% | 14.52% | 12.99% |
| Operating Income | -84.73% | -48.89% | -21.95% | 91.61% | -58.31% |
| Income Before Tax | -163.45% | -95.76% | -231.84% | -39.91% | -60.42% |
| Income Tax Expenses | -319.14% | -102.39% | -395.20% | -155.49% | 81.58% |
| Earnings from Continuing Operations | -116.27% | -51.13% | -131.40% | 25.41% | -64.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 155.20% | 59.15% | 91.05% | -49.17% | -177.93% |
| Net Income | -114.09% | 32.38% | -38.72% | 10.36% | -67.11% |
| EBIT | -84.73% | -48.89% | -21.95% | 91.61% | -58.31% |
| EBITDA | -61.78% | -37.12% | -0.83% | 66.89% | -50.53% |
| EPS Basic | -114.12% | 35.29% | -38.58% | 11.27% | -67.56% |
| Normalized Basic EPS | -164.28% | -104.27% | -45.83% | -96.23% | -66.23% |
| EPS Diluted | -115.00% | 35.29% | -38.58% | 11.27% | -68.92% |
| Normalized Diluted EPS | -168.32% | -104.34% | -45.83% | -93.21% | -67.68% |
| Average Basic Shares Outstanding | -0.08% | -0.03% | 0.01% | 1.05% | 1.35% |
| Average Diluted Shares Outstanding | -5.95% | -1.11% | 0.01% | 2.66% | 5.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |